Efficiency and Safety of High-frequency Radio Wave Electrotherapy With a Radio Frequency of 448 kHz in the Treatment of Patients With Organic Erectile Dysfunction.

Inclusion Criteria: 1. Patients aged 18 to 79 years; 2. The diagnosis is confirmed by assessing the functional criteria of arterial factors of panel hemodynamics (dopplerography); 3. The diagnosis is confirmed by the assessment of the IIEF-5 questionnaire 4. Patients with organic erectile dysfunction lasting at least 6 months. 5. Patients with IIEF from 6 to 22 points. 6. Patients with a permanent sexual partner for more than 3 months; 7. Sexually Active Patients. Non-inclusion criteria: 1. The use of other treatments for erectile dysfunction 2. Age under 18 and over 79 years old; 3. Anatomical deformation of the penis (angulation, cavernous fibrosis or Peyronie's disease); 4. The presence of diseases predisposing to the development of priapism (sickle cell anemia, multiple myeloma, leukemia, thrombocytopenia); 5. Running coagulation disorders; 6. The presence of tumors in the area of electrotherapy; 7. The presence of aneurysms in the propagation of radio frequency waves; 8. Angina pectoris; 9. Myocardial infarction, stroke, life-threatening arrhythmias; 10. Thrombosis, thromboembolic disease; 11. Arterial hypertension (blood pressure ≥ 170/90 mm Hg) or hypotension (blood pressure ≤ 90/50 mm Hg.); 12. The patient has a mental illness that does not allow an assessment of the effectiveness of therapy; history of alcoholism and drug addiction; 14\. Active tuberculosis, chronic somatic diseases in the acute stage; 15. Condition after coronary artery bypass grafting (CABG); 16. Patient's involvement in another clinical trial in the last 3 months; Exclusion Criteria: 1. Serious unwanted phenomenons associated with exposure to the apparatus. 2. Incorrect inclusion in the study. 3. A marked deterioration in the patient's condition due to an increase in the severity of the disease or the attachment of another disease. 4. The patient's appearance of non-inclusion criteria during the study. 5. Serious deviation from the protocol. 6. The desire of the patient or his legal representative.